About

Publications While At HealthPartners

selected publications

Journal Article

North Central Cancer Treatment Group N0543 (Alliance): a phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma. 

Cancer. 2017

Contact

full name

T. J. Hobday

Quick Info

 

Collaboration

Co-author network

Map of science